Filing Details

Accession Number:
0001209191-21-053544
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-26 19:08:27
Reporting Period:
2021-08-24
Accepted Time:
2021-08-26 19:08:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404644 Neoleukin Therapeutics Inc. NLTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588467 G Jonathan Drachman C/O Neoleukin Therapeutics, Inc.
188 East Blaine Street, #450
Seattle WA 98102
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-24 100,000 $6.11 2,348,686 No 4 P Direct
Common Stock Acquisiton 2021-08-25 25,000 $6.45 25,000 No 4 P Indirect See footnote
Common Stock Acquisiton 2021-08-25 25,000 $6.45 25,000 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.1099 and the highest price at which shares were purchased was $6.1482. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.09 and the highest price at which shares were purchased was $6.60.
  3. These securities are held by a spousal limited access trust of which the Reporting Person is the primary beneficiary.
  4. These securities are held by a spousal limited access trust of which the Reporting Person's spouse is the primary beneficiary.